ARGX CIK: 1697862

argenx SE

  • Netherlands
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
2.54
FY22:
2.77
FY23:
4.12
FY24:
4.88
FY25:
6.90
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.31
FY22:
0.36
FY23:
0.42
FY24:
1.32
FY25:
1.78
Total assets
Change from FY21 to FY25
billions USD
FY21:
2.85
FY22:
3.13
FY23:
4.54
FY24:
6.20
FY25:
8.68

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.30
FY22:
0.30
FY23:
0.42
FY24:
0.67
FY25:
1.32
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.02
FY23:
0.02
FY24:
0.03
FY25:
0.04
(positive)
Change from FY21 to FY25
billions USD
FY21:
2.53
FY22:
2.81
FY23:
4.10
FY24:
5.50
FY25:
7.32
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
2.85
FY22:
3.13
FY23:
4.54
FY24:
6.20
FY25:
8.68

All amounts in billions USD Data sources:SEC EDGARTwelve Data